The Global SARS-CoV-2 Vaccine (Vero Cell) Market was valued at US$ 952.2 million in 2024 and is projected to reach US$ 1.4 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period (2024-2030).
Report Overview
SARS-Cov-2 Vaccine (Vero Cell) is an immune product made to prevent and control the occurrence and prevalence of infectious diseases caused by the new coronavirus
This report provides a deep insight into the global SARS-Cov-2 Vaccine (Vero Cell) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global SARS-Cov-2 Vaccine (Vero Cell) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the SARS-Cov-2 Vaccine (Vero Cell) market in any manner.
Global SARS-Cov-2 Vaccine (Vero Cell) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Sinopharm
- Sinovac Biotech
- BIBP
- IMBCAMS,China
- WIBP
- Pfizer
Market Segmentation (by Type)
- Whole Virus Inactivated Vaccine
- Split Vaccine
- Subunit Vaccine
- Others
Market Segmentation (by Application)
- Special Population
- General Population
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the SARS-Cov-2 Vaccine (Vero Cell) Market
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical
scope of the report, market division standards, and market research methods.
Chapter 2 is an executive
summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the SARS-Cov-2 Vaccine (Vero Cell) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of SARS-Cov-2 Vaccine (Vero Cell)
1.2 Key Market Segments
1.2.1 SARS-Cov-2 Vaccine (Vero Cell) Segment by Type
1.2.2 SARS-Cov-2 Vaccine (Vero Cell) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SARS-Cov-2 Vaccine (Vero Cell) Market Overview
2.1 Global Market Overview
2.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SARS-Cov-2 Vaccine (Vero Cell) Market Competitive Landscape
3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Manufacturers (2019-2024)
3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Manufacturers (2019-2024)
3.3 SARS-Cov-2 Vaccine (Vero Cell) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global SARS-Cov-2 Vaccine (Vero Cell) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Sales Sites, Area Served, Product Type
3.6 SARS-Cov-2 Vaccine (Vero Cell) Market Competitive Situation and Trends
3.6.1 SARS-Cov-2 Vaccine (Vero Cell) Market Concentration Rate
3.6.2 Global 5 and 10 Largest SARS-Cov-2 Vaccine (Vero Cell) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SARS-Cov-2 Vaccine (Vero Cell) Industry Chain Analysis
4.1 SARS-Cov-2 Vaccine (Vero Cell) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of SARS-Cov-2 Vaccine (Vero Cell) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SARS-Cov-2 Vaccine (Vero Cell) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2019-2024)
6.3 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Market Share by Type (2019-2024)
6.4 Global SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2019-2024)
7 SARS-Cov-2 Vaccine (Vero Cell) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global SARS-Cov-2 Vaccine (Vero Cell) Market Sales by Application (2019-2024)
7.3 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size (M USD) by Application (2019-2024)
7.4 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate by Application (2019-2024)
8 SARS-Cov-2 Vaccine (Vero Cell) Market Segmentation by Region
8.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region
8.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region
8.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region
8.2 North America
8.2.1 North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Sinopharm
9.1.1 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Basic Information
9.1.2 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Overview
9.1.3 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Market Performance
9.1.4 Sinopharm Business Overview
9.1.5 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) SWOT Analysis
9.1.6 Sinopharm Recent Developments
9.2 Sinovac Biotech
9.2.1 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Basic Information
9.2.2 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Overview
9.2.3 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Market Performance
9.2.4 Sinovac Biotech Business Overview
9.2.5 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) SWOT Analysis
9.2.6 Sinovac Biotech Recent Developments
9.3 BIBP
9.3.1 BIBP SARS-Cov-2 Vaccine (Vero Cell) Basic Information
9.3.2 BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Overview
9.3.3 BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Market Performance
9.3.4 BIBP SARS-Cov-2 Vaccine (Vero Cell) SWOT Analysis
9.3.5 BIBP Business Overview
9.3.6 BIBP Recent Developments
9.4 IMBCAMS,China
9.4.1 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Basic Information
9.4.2 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Overview
9.4.3 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Market Performance
9.4.4 IMBCAMS,China Business Overview
9.4.5 IMBCAMS,China Recent Developments
9.5 WIBP
9.5.1 WIBP SARS-Cov-2 Vaccine (Vero Cell) Basic Information
9.5.2 WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Overview
9.5.3 WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Market Performance
9.5.4 WIBP Business Overview
9.5.5 WIBP Recent Developments
9.6 Pfizer
9.6.1 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Basic Information
9.6.2 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product Overview
9.6.3 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product Market Performance
9.6.4 Pfizer Business Overview
9.6.5 Pfizer Recent Developments
10 SARS-Cov-2 Vaccine (Vero Cell) Market Forecast by Region
10.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast
10.2 Global SARS-Cov-2 Vaccine (Vero Cell) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country
10.2.3 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Region
10.2.4 South America SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of SARS-Cov-2 Vaccine (Vero Cell) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of SARS-Cov-2 Vaccine (Vero Cell) by Type (2025-2030)
11.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of SARS-Cov-2 Vaccine (Vero Cell) by Type (2025-2030)
11.2 Global SARS-Cov-2 Vaccine (Vero Cell) Market Forecast by Application (2025-2030)
11.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons) Forecast by Application
11.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. SARS-Cov-2 Vaccine (Vero Cell) Market Size Comparison by Region (M USD)
Table 5. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-Cov-2 Vaccine (Vero Cell) as of 2022)
Table 10. Global Market SARS-Cov-2 Vaccine (Vero Cell) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Sales Sites and Area Served
Table 12. Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Product Type
Table 13. Global SARS-Cov-2 Vaccine (Vero Cell) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of SARS-Cov-2 Vaccine (Vero Cell)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. SARS-Cov-2 Vaccine (Vero Cell) Market Challenges
Table 22. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (Kilotons)
Table 23. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Type (M USD)
Table 24. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons) by Type (2019-2024)
Table 25. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2019-2024)
Table 26. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size (M USD) by Type (2019-2024)
Table 27. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Share by Type (2019-2024)
Table 28. Global SARS-Cov-2 Vaccine (Vero Cell) Price (USD/Ton) by Type (2019-2024)
Table 29. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons) by Application
Table 30. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Application
Table 31. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2019-2024)
Table 33. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2019-2024) & (M USD)
Table 34. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Application (2019-2024)
Table 35. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate by Application (2019-2024)
Table 36. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2019-2024)
Table 38. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2019-2024) & (Kilotons)
Table 43. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Basic Information
Table 44. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Overview
Table 45. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sinopharm Business Overview
Table 47. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) SWOT Analysis
Table 48. Sinopharm Recent Developments
Table 49. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Basic Information
Table 50. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Overview
Table 51. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sinovac Biotech Business Overview
Table 53. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) SWOT Analysis
Table 54. Sinovac Biotech Recent Developments
Table 55. BIBP SARS-Cov-2 Vaccine (Vero Cell) Basic Information
Table 56. BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Overview
Table 57. BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. BIBP SARS-Cov-2 Vaccine (Vero Cell) SWOT Analysis
Table 59. BIBP Business Overview
Table 60. BIBP Recent Developments
Table 61. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Basic Information
Table 62. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Overview
Table 63. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. IMBCAMS,China Business Overview
Table 65. IMBCAMS,China Recent Developments
Table 66. WIBP SARS-Cov-2 Vaccine (Vero Cell) Basic Information
Table 67. WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Overview
Table 68. WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. WIBP Business Overview
Table 70. WIBP Recent Developments
Table 71. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Basic Information
Table 72. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product Overview
Table 73. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Pfizer Business Overview
Table 75. Pfizer Recent Developments
Table 76. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 77. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 79. North America SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 81. Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 83. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 85. South America SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 89. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global SARS-Cov-2 Vaccine (Vero Cell) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 91. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons) Forecast by Application (2025-2030)
Table 92. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of SARS-Cov-2 Vaccine (Vero Cell)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size (M USD), 2019-2030
Figure 5. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size (M USD) (2019-2030)
Figure 6. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country (M USD)
Figure 11. SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Manufacturers in 2023
Figure 12. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Manufacturers in 2023
Figure 13. SARS-Cov-2 Vaccine (Vero Cell) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market SARS-Cov-2 Vaccine (Vero Cell) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by SARS-Cov-2 Vaccine (Vero Cell) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Type
Figure 18. Sales Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Type (2019-2024)
Figure 19. Sales Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Type in 2023
Figure 20. Market Size Share of SARS-Cov-2 Vaccine (Vero Cell) by Type (2019-2024)
Figure 21. Market Size Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Application
Figure 24. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2019-2024)
Figure 25. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application in 2023
Figure 26. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Application (2019-2024)
Figure 27. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Application in 2023
Figure 28. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate by Application (2019-2024)
Figure 29. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2019-2024)
Figure 30. North America SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2023
Figure 32. U.S. SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada SARS-Cov-2 Vaccine (Vero Cell) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico SARS-Cov-2 Vaccine (Vero Cell) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2023
Figure 37. Germany SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region in 2023
Figure 44. China SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (Kilotons)
Figure 50. South America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country in 2023
Figure 51. Brazil SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa SARS-Cov-2 Vaccine (Vero Cell) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share Forecast by Type (2025-2030)
Figure 65. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Application (2025-2030)
Figure 66. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share Forecast by Application (2025-2030)
